Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors
Most anticancer therapies to date focus on druggable features of tumor epithelia. Despite the increasing repertoire of treatment options, patient responses remain varied. Moreover, tumor resistance and relapse remain persistent clinical challenges. These observations imply an incomplete understandin...
| Главные авторы: | , , , , , |
|---|---|
| Другие авторы: | |
| Формат: | Journal Article |
| Язык: | English |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://hdl.handle.net/10356/90275 http://hdl.handle.net/10220/48495 |